4.2 Article

Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure

期刊

JOURNAL OF HUMAN HYPERTENSION
卷 26, 期 5, 页码 295-305

出版社

SPRINGERNATURE
DOI: 10.1038/jhh.2011.31

关键词

grey matter volume; brain atrophy; magnetic resonance imaging

资金

  1. NIH [NHLBI HL57529]
  2. PJG [HL-R01-089850, MH-K01-070616]
  3. NR [R37, AG011230]
  4. ADNI (NIH) [U01 AG024904]
  5. National Institute on Aging
  6. National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  7. Pfizer Inc.
  8. Wyeth Research
  9. Bristol-Myers Squibb
  10. Eli Lilly and Company
  11. GlaxoSmithKline
  12. Merck Co. Inc.
  13. AstraZeneca AB
  14. Novartis Pharmaceuticals Corporation
  15. Alzheimer's Association
  16. Eisai Global Clinical Development, Elan Corporation Plc
  17. Forest Laboratories
  18. Institute for the Study of Aging
  19. US Food and Drug Administration

向作者/读者索取更多资源

The aim of the study was to determine whether the reduction in brain grey matter volume associated with hypertension persisted or was remediated among hypertensive patients newly treated over the course of a year. A total of 41 hypertensive patients were assessed over the course of a 1-year successful anti-hypertensive treatment. Brain areas identified previously in cross-sectional studies differing in volume between hypertensive and normotensive individuals were examined with a semi-automated measurement technique (automated labelling pathway). Volumes of grey matter regions were computed at baseline after a year of treatment and compared with archival data from normotensive individuals. Reductions in regional grey matter volume over the follow-up period were observed despite successful treatment of blood pressure (BP). The comparison group of older, but normotensive, individuals showed no significant changes over a year in the regions tested in the treated hypertensive group. These novel results suggest that essential hypertension is associated with regional grey matter shrinkage, and successful reduction of BP may not completely counter that trend. Journal of Human Hypertension (2012) 26, 295-305; doi:10.1038/jhh.2011.31; published online 14 April 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据